Stockscreener 앱 받기
4.42
3.76%
0.16
시간 외 거래:
4.42
전일 마감가:
$4.26
열려 있는:
$4.26
하루 거래량:
615.56K
Relative Volume:
0.62
시가총액:
$277.43M
수익:
-
순이익/손실:
$-96.66M
주가수익비율:
-2.0558
EPS:
-2.15
순현금흐름:
$-83.73M
1주 성능:
+29.62%
1개월 성능:
-0.67%
6개월 성능:
-64.09%
1년 성능:
-58.73%
1일 변동 폭
$4.215
$4.44
1주일 범위
$3.30
$4.44
52주 변동 폭
$2.86
$16.62
올레마 Stock (OLMA) Company Profile
명칭
Olema Pharmaceuticals Inc
전화
(415) 651-3316
주소
780 BRANNAN STREET, SAN FRANCISCO
OLMA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OLMA
Olema Pharmaceuticals Inc
|
4.42 | 277.43M | 0 | -96.66M | -83.73M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
올레마 Stock (OLMA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-04-02 | 개시 | Goldman | Buy |
| 2024-01-30 | 개시 | Citigroup | Buy |
| 2023-07-21 | 개시 | Oppenheimer | Outperform |
| 2023-05-05 | 개시 | CapitalOne | Overweight |
| 2023-02-22 | 개시 | Credit Suisse | Outperform |
| 2022-07-06 | 재개 | Canaccord Genuity | Buy |
| 2022-06-09 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2022-02-28 | 개시 | H.C. Wainwright | Neutral |
| 2021-12-07 | 재개 | Cowen | Outperform |
| 2020-12-14 | 개시 | Canaccord Genuity | Buy |
| 2020-12-14 | 개시 | Cowen | Outperform |
| 2020-12-14 | 개시 | JP Morgan | Overweight |
| 2020-12-14 | 개시 | Jefferies | Buy |
모두보기
올레마 주식(OLMA)의 최신 뉴스
Vanguard Group Inc. Grows Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Alliancebernstein L.P. Has $1.83 Million Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Franklin Resources Inc. Acquires 258,625 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
American Century Companies Inc. Reduces Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Wellington Management Group LLP Purchases 522,799 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
KLP Kapitalforvaltning AS Takes Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
After Plunging -30.16% in 4 Weeks, Here's Why the Trend Might Reverse for Olema Pharmaceuticals (OLMA) - Yahoo Finance
Wellington Management Group LLP Has $8.84 Million Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - The AM Reporter
Schroder Investment Management Group Increases Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Olema Pharmaceuticals: Maybe Not Differentiated, But Could Find A Niche In A Valuable Market - Seeking Alpha
Pictet Asset Management Holding SA Has $10.98 Million Stake in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
HighTower Advisors LLC Invests $510,000 in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
10,352 Shares in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Bought by Teacher Retirement System of Texas - Defense World
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Olema Expands Team: 5 Key Hires Receive Equity Compensation Package - Stock Titan
Top Premarket Decliners - MarketScreener
Insiders Could Have Profited By Holding onto Olema Pharmaceuticals Shares Despite 13% Drop - simplywall.st
JPMorgan Chase & Co. Cuts Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $28.00 - MarketBeat
Olema Pharmaceuticals stock hits 52-week low at $3.86 By Investing.com - Investing.com South Africa
Olema Pharmaceuticals stock hits 52-week low at $3.86 - Investing.com
HighTower Advisors LLC Takes $510,000 Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
JPMorgan Chase & Co. Lowers Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $28.00 - Defense World
Pier Capital LLC Acquires New Shares in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Bank of New York Mellon Corp Trims Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Olema Oncology to Present Preclinical Data for OP-3136, a - GlobeNewswire
Victory Capital Management Inc. Cuts Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Cancer Breakthrough: New Drug Shows Powerful Anti-Tumor Effects in Prostate, Ovarian, Lung Cancers - Stock Titan
What is Lifesci Capital's Estimate for OLMA FY2025 Earnings? - MarketBeat
What is HC Wainwright's Forecast for OLMA FY2029 Earnings? - MarketBeat
Olema Pharmaceuticals' (OLMA) "Outperform" Rating Reiterated at Oppenheimer - MarketBeat
HC Wainwright Reaffirms "Buy" Rating for Olema Pharmaceuticals (NASDAQ:OLMA) - MarketBeat
HC Wainwright Issues Optimistic Estimate for OLMA Earnings - MarketBeat
Olema Pharmaceuticals (NASDAQ:OLMA) Releases Earnings Results - MarketBeat
Olema Pharmaceuticals (NASDAQ:OLMA) Posts Quarterly Earnings Results, Beats Estimates By $0.12 EPS - MarketBeat
Victory Capital Management Inc. Sells 758,412 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
HC Wainwright Issues Optimistic Outlook for OLMA Earnings - Defense World
FY2025 EPS Estimate for Olema Pharmaceuticals Cut by Analyst - Defense World
Olema Pharmaceuticals Inc (OLMA) Shares Rise Despite Market Challenges - The News Heater
올레마 (OLMA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.51%
자본화:
|
볼륨(24시간):